Effectiveness and safety of inhaled corticosteroids in older individuals with chronic obstructive pulmonary disease and/or asthma. A population study
… the use of ICS in real-life older individuals with chronic airway disease, we conducted a
longitudinal population cohort study to compare the effectiveness and safety of ICS in older …
longitudinal population cohort study to compare the effectiveness and safety of ICS in older …
The safety of long-term use of inhaled corticosteroids in patients with asthma: a systematic review and meta-analysis
W Shang, G Wang, Y Wang, D Han - Clinical Immunology, 2022 - Elsevier
Purpose This systematic review and meta-analysis was performed to determine the safety of
long-term use of ICS in patients with asthma. Methods A systematic search was made of …
long-term use of ICS in patients with asthma. Methods A systematic search was made of …
Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD
M Miravitlles, A Auladell-Rispau… - European …, 2021 - Eur Respiratory Soc
… term corticosteroid-related side-effects. This is particularly important in COPD, because the
population affected is usually older individuals with … to being aggravated by corticosteroids [8]. …
population affected is usually older individuals with … to being aggravated by corticosteroids [8]. …
Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
T Jo, H Yasunaga, Y Yamauchi, A Mitani… - ERJ Open …, 2020 - Eur Respiratory Soc
… use of ICSs, are mainly extrapolated from studies of patients … between ICS withdrawal in
elderly patients with COPD and … or the frequency of oral corticosteroid prescriptions at either 30 …
elderly patients with COPD and … or the frequency of oral corticosteroid prescriptions at either 30 …
Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review
R Patel, SA Naqvi, C Griffiths… - BMJ Open Respiratory …, 2020 - bmjopenrespres.bmj.com
… Oral corticosteroid use increases the risk of systemic adverse effects including osteoporosis,
… We sought to understand if inhaled corticosteroid (ICS) use in asthma is also associated …
… We sought to understand if inhaled corticosteroid (ICS) use in asthma is also associated …
[HTML][HTML] Inhaled corticosteroids in asthma and the risk of pneumonia
MH Kim, CK Rhee, JS Shim, SY Park… - Allergy, Asthma & …, 2019 - ncbi.nlm.nih.gov
… The total number of asthma patients was 831,613. Patients using ICS were older and had
more comorbidities than those not using ICS; they also visited outpatient clinics and …
more comorbidities than those not using ICS; they also visited outpatient clinics and …
Usage patterns of short-acting β2-agonists and inhaled corticosteroids in asthma: a targeted literature review
… We observed that patients of certain ethnicities, such as black and Hispanic patients,
patients living in rural areas, older patients, and patients with lower socioeconomic status, were …
patients living in rural areas, older patients, and patients with lower socioeconomic status, were …
Association between inhaled corticosteroid use and COVID‐19 outcomes
… For sensitivity analyses, we also constructed nationwide cohorts of all individuals aged
40 years or older who tested positive for SARS-CoV-2 or influenza while out-of-hospital to …
40 years or older who tested positive for SARS-CoV-2 or influenza while out-of-hospital to …
Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study
C Janson, K Lisspers, B Ställberg… - European …, 2021 - Eur Respiratory Soc
… use of inhaled corticosteroids (ICS) in patients who are at high risk of exacerbations and
elevated blood eosinophil levels or patients … found to be higher in females and elderly patients. …
elevated blood eosinophil levels or patients … found to be higher in females and elderly patients. …
Risk of pneumonia with different inhaled corticosteroids in COPD patients: a meta-analysis
Q Zhang, S Li, W Zhou, X Yang, J Li… - COPD: Journal of …, 2020 - Taylor & Francis
… 65 years old, lowest baseline forced expiratory volume in the first second of expiration (FEV1)
< 50% of the predicted value, highest ICS dose, and long duration of ICS use. Furthermore…
< 50% of the predicted value, highest ICS dose, and long duration of ICS use. Furthermore…
相关搜索
- swedish copd patients inhaled corticosteroid use
- fracture in older people inhaled corticosteroids
- elderly patients inhaled corticosteroid withdrawal
- inhaled corticosteroid use in asthma
- association of osteoporosis inhaled corticosteroid use
- covid 19 outcomes inhaled corticosteroid use
- pneumonia in copd patients inhaled corticosteroid
- disease patients inhaled corticosteroids on mortality
- risk of pneumonia inhaled corticosteroid use
- usage patterns inhaled corticosteroids
- meta analysis inhaled corticosteroids
- chronic obstructive pulmonary disease inhaled corticosteroids
- systemic adverse effects inhaled corticosteroid use
- arctic study inhaled corticosteroid use
- systematic review inhaled corticosteroid use
- randomized controlled trials inhaled corticosteroids